-
Intendis GmbH et al v. Glenmark Pharmaceuticals Ltd. et al DC CAFC
- 1:13-cv-00421
- D. Del.
- Judge: Sue L. Robinson
- Filed: 03/14/2013
- Closed: 07/27/2015
- Latest Docket Entry: 11/10/2016
- PACER
- Docket updated daily
3
Plaintiffs
4
Defendants
1
Accused
Product
1
Patent-in-Suit
866
Days in
Litigation
-
Intendis GmbH et al v. Glenmark Pharmaceuticals Ltd. et al DC CAFC
- 1:13-cv-00421
- D. Del.
- Judge: Sue L. Robinson
- Filed: 03/14/2013
- Closed: 07/27/2015
- Latest Docket Entry: 11/10/2016
- PACER
- Docket updated daily
Cause of Action
Infringement
Market Sector
Biotech and Pharma
Court
Assigned Judge
Outcome Summary
- Patent Information
-
Validity & Enforceability
| Claim | Outcome |
|---|---|
| All challenged claims |
Valid
Entry 143 |
-
Infringement
Glenmark Generics Limited
- 1 Detail
| Accused Product | Patent # | Claim # | Outcome |
|---|---|---|---|
| 15 % Generic Azelaic Acid Gel | US 6,534,070 B1 |
1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12
|
Infringement
Entry 150
|
| Accused Product | Patent # | Claim # | Outcome |
|---|---|---|---|
| 15 % Generic Azelaic Acid Gel | US 6,534,070 B1 |
1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12
|
Infringement
Entry 150
|
